SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Maggio Marcello)
 

Sökning: WFRF:(Maggio Marcello) > Safety and tolerabi...

Safety and tolerability of 6-month supplementation with a vitamin D, calcium and leucine-enriched whey protein medical nutrition drink in sarcopenic older adults

Bauer, Juergen M. (författare)
Heidelberg Univ, Ctr Geriatr Med, Agaples Bethanien Krankenhaus Heidelberg, Heidelberg, Germany
Mikusova, Lucia (författare)
Danone Nutricia Res, Nutricia Adv Med Nutr, Utrecht, Netherlands
Verlaan, Sjors (författare)
Univ Amsterdam, Med Ctr, VU, Dept Internal Med,Sect Gerontol & Geriatr, Amsterdam, Netherlands
visa fler...
Bautmans, Ivan (författare)
Vrije Univ Brussel, Frailty Ageing Res Grp FRIA, Brussels, Belgium
Brandt, Kirsten (författare)
Newcastle Univ, Inst Ageing, Sch Agr Food & Rural Dev, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England
Donini, Lorenzo M. (författare)
Sapienza Univ Rome, Dept Expt Med, Sect Med Pathophysiol Endocrinol & Human Nutr, Rome, Italy
Maggio, Marcello (författare)
Univ Parma, Sect Geriatr, Dept Clin & Expt Med, Parma, Italy
Mets, Tony (författare)
Vrije Univ Brussel, Frailty Ageing Res Grp FRIA, Brussels, Belgium
Wijers, Sander L. J. (författare)
Danone Nutricia Res, Nutricia Adv Med Nutr, Utrecht, Netherlands
Garthoff, Jossie A. (författare)
Danone Food Safety Ctr, Utrecht, Netherlands
Luiking, Yvette (författare)
Danone Nutricia Res, Nutricia Adv Med Nutr, Utrecht, Netherlands
Sieber, Cornel (författare)
Friedrich Alexander Univ Erlangen Nurnberg, Erlangen, Germany
Cederholm, Tommy (författare)
Karolinska Institutet,Uppsala universitet,Klinisk nutrition och metabolism,Geriatrik
visa färre...
 (creator_code:org_t)
2020-03-12
2020
Engelska.
Ingår i: Aging Clinical and Experimental Research. - : Springer Nature. - 1594-0667 .- 1720-8319. ; 32:8, s. 1501-1514
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Aims Safety and tolerability of prolonged supplementation with a vitamin D, calcium and leucine-enriched whey protein medical nutrition drink (WP-MND) was evaluated in sarcopenic older adults.Methods A 13-week double-blinded, randomized, isocaloric placebo-controlled trial (PROVIDE study;n = 380) was extended with a voluntary 13-week open-label extension (OLE). OLE participants were randomized to receive daily 1 or 2 servings of WP-MND (21 g protein, 3 g leucine, 10 mu g vitD and 500 mg calcium per serving). Gastro-intestinal tolerability, kidney function and serum levels of calcidiol, parathyroid hormone (PTH) and calcium were evaluated at week 0, 13 and 26.Results and discussion In response to the high daily protein intake (median1.5; IQR: 1.3, 1.7 g/kg BW/day), the estimated glomerular filtration rate (eGFR) increased in the test group during the RCT (p = 0.013). The same trend was observed for those participants with moderate chronic kidney disease. During OLE no eGFR change was observed in any of the groups. Serum calcidiol and calcium reached a plateau after 13-week WP-MND supplementation. As expected, PTH significantly changed in the opposite direction, decreasing during RCT in the test group (T vs C:p < 0.001) and during OLE in former control groups. During RCT, 20/366 participants with normal baseline calcidiol reached levels >= 100 nmol/L (T:n = 18; C:n = 2) and 6 developed albumin-corrected calcium levels > 2.55 mmol/L (T:n = 3; C:n = 3), without associated adverse events.Conclusion A 6 months intervention with up to 2 servings of WP-MND did neither result in kidney function deterioration nor symptoms of vitamin D or calcium toxicity. The product was overall well tolerated.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Hälsovetenskap -- Näringslära (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Health Sciences -- Nutrition and Dietetics (hsv//eng)

Nyckelord

Nutrition
Safety
Tolerability
Sarcopenia
Whey protein
Vitamin D

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy